Definition of Brazikumab. Meaning of Brazikumab. Synonyms of Brazikumab

Here you will find one or more explanations in English for the word Brazikumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Brazikumab and, of course, Brazikumab synonyms and on the right images related to the word Brazikumab.

Definition of Brazikumab

No result for Brazikumab. Showing similar results...

Meaning of Brazikumab from wikipedia

- Brazikumab (INN; development code MEDI2070) is a human monoclonal antibody designed for the treatment of Crohn's disease. that targets IL-23. This drug...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- humanized SOST osteoporosis Bococizumab mab humanized PCSK9 dyslipidemia Brazikumab mab human IL-23 Crohn's disease Brentuximab vedotin Adcentris mab chimeric...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...
- Fezakinumab (against IL-22) IL-23 Agonists: Interleukin 23 (SGRF) Antibodies: Brazikumab Briakinumab Guselkumab Risankizumab Tildrakizumab Ustekinumab IL-27 Agonists:...